一份病例报告:与MSH2中生殖系异构基因突变相关的质肉瘤
1Medical School, Nanjing University, Nanjing, China.
Frontiers in neurology
|May 24, 2024
概括
一个罕见的质肉瘤病例与林奇综合征 (LS) 相关,这是一种遗传性癌症易感综合征. 这强调了对多种瘤患者进行基因检测的重要性,特别是那些有结肠癌病史的患者.
科学领域:
- 神经瘤学神经瘤学
- 遗传学 遗传学 是一个
- 胃肠病学 胃肠病学
背景情况:
- 质肉瘤是一种罕见的质母细胞瘤亚型,预后不佳.
- 虽然大多是零星的,但一些类瘤与遗传性癌症综合征有关,如林奇综合征 (LS).
研究的目的:
- 在患有林奇综合征的患者中报告一次性MMRD质肉瘤病例.
- 强调在神经外科瘤学中识别遗传性倾向的重要性.
- 强调遗传检测在诊断LS中的作用.
主要方法:
- 一个54岁的男性患有质肉瘤的案例介绍.
- 分析患者病史,包括结肠恶性瘤和直肠癌家族病史.
- 手术后的组织病理学证实了质肉瘤,MSI-H和MMRD.
- 鉴定MSH2突变的生殖系遗传检测.
主要成果:
- 这名患者被诊断出患有初级不匹配修复缺陷质肉瘤.
- 基因检测证实了生殖系MSH2突变,诊断出林奇综合征.
- 这些发现将质肉瘤与LS中的生殖系MSH2突变联系起来.
结论:
- 这一案例扩大了与生殖系MSH2突变相关的类瘤的理解.
- 神经外科医生应考虑在有外神经恶性瘤病史的患者中遗传性疾病.
- 基因检测对于识别林奇综合征和指导患者管理至关重要.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.9K
08:52Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
8.9K
相关概念视频
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
